# Intrawound Vancomycin Prophylaxis for Neural Stimulator

> **NCT03221023** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 900 (estimated)

## Conditions studied

- Vancomycin
- Implantable Neural Stimulator
- Deep Brain Stimulation
- Surgical Site Infection

## Interventions

- **DRUG:** Vancomycin Hydrochloride
- **DRUG:** Saline Solution

## Key facts

- **NCT ID:** NCT03221023
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-15
- **Primary completion:** 2021-09-15
- **Final completion:** 2021-12-15
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2020-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03221023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03221023, "Intrawound Vancomycin Prophylaxis for Neural Stimulator". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03221023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*